Drug Shortage Report for VISUDYNE
Report ID | 165082 |
Drug Identification Number | 02242367 |
Brand name | VISUDYNE |
Common or Proper name | verteporfin |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | VERTEPORFIN |
Strength(s) | 15MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 15ml |
ATC code | S01LA |
ATC description | OCULAR VASCULAR DISORDER AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-07-27 |
Actual start date | |
Estimated end date | 2022-08-27 |
Actual end date | 2022-08-12 |
Shortage status | Resolved |
Updated date | 2022-08-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-08-13 | English | Compare |
v5 | 2022-08-12 | French | Compare |
v4 | 2022-08-12 | English | Compare |
v3 | 2022-07-28 | English | Compare |
v2 | 2022-07-20 | French | Compare |
v1 | 2022-07-20 | English | Compare |
Showing 1 to 6 of 6